Senseonics Holdings Inc (NYSEMKT:SENS) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Wednesday.

According to Zacks, “Senseonics Holdings, Inc. is a medical technology company which focused on the design, development and commercialization of glucose monitoring systems. Senseonics Holdings, Inc. is based in Germantown, United States. “

SENS has been the subject of several other research reports. Canaccord Genuity reiterated a “buy” rating and set a $6.00 price target on shares of Senseonics Holdings in a research note on Wednesday, August 10th. Leerink Swann reiterated an “outperform” rating and set a $6.00 price target (up previously from $4.50) on shares of Senseonics Holdings in a research note on Thursday, September 22nd. Finally, B. Riley initiated coverage on Senseonics Holdings in a research note on Monday, September 26th. They set a “buy” rating and a $5.50 price target for the company. One equities research analyst has rated the stock with a sell rating and five have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $5.17.

Analyst Recommendations for Senseonics Holdings (NYSEMKT:SENS)

Senseonics Holdings (NYSEMKT:SENS) opened at 2.33 on Wednesday. The firm’s 50-day moving average price is $3.13 and its 200 day moving average price is $3.55. The firm’s market cap is $217.60 million. Senseonics Holdings has a 52 week low of $2.22 and a 52 week high of $4.24.

Senseonics Holdings (NYSEMKT:SENS) last announced its quarterly earnings data on Thursday, November 3rd. The company reported ($0.12) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.11) by $0.01. Equities analysts forecast that Senseonics Holdings will post ($0.51) earnings per share for the current fiscal year.

Hedge funds and other institutional investors have recently modified their holdings of the company. California State Teachers Retirement System increased its position in shares of Senseonics Holdings by 1.0% in the third quarter. California State Teachers Retirement System now owns 58,911 shares of the company’s stock valued at $230,000 after buying an additional 600 shares in the last quarter. Northern Trust Corp increased its position in shares of Senseonics Holdings by 2.7% in the third quarter. Northern Trust Corp now owns 273,003 shares of the company’s stock valued at $1,064,000 after buying an additional 7,286 shares in the last quarter. Spark Investment Management LLC increased its position in shares of Senseonics Holdings by 27.7% in the third quarter. Spark Investment Management LLC now owns 86,600 shares of the company’s stock valued at $337,000 after buying an additional 18,800 shares in the last quarter. Highland Capital Management LLC bought a new position in shares of Senseonics Holdings during the third quarter valued at approximately $116,000. Finally, Oak Ridge Investments LLC bought a new position in shares of Senseonics Holdings during the third quarter valued at approximately $125,000.

Senseonics Holdings Company Profile

Senseonics Holdings, Inc, formerly ASN Technologies, Inc, is a medical technology company. The Company is focused on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed to be an implantable CGM system to continually measure glucose levels in people with diabetes for a period of approximately 90 days.

Receive News & Stock Ratings for Senseonics Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics Holdings Inc and related stocks with our FREE daily email newsletter.